iLIVER Open Access Editor-in-Chief: Jiahong Dong
Home iLIVER All Issues Volume 3 Issue 2
Volume 3 Issue 2, June 2024
8 articles
|
Next Issue
Editorial | Open Access
Liver transplantation and immune toleran Setting the stage for optimal post-transplant status
Published: 20 May 2024
2024, 3 (2): 100097
Original Article | Open Access
Diagnostic performance comparisons of two commonly used multi-biomarker-based scores for detection of hepatocellular carcinoma in non-alcoholic fatty liver disease
Published: 21 May 2024
2024, 3 (2): 100098
Original Article | Open Access
Setting up an integrated service for PSC-IBD patients: A quality improvement project
Published: 05 February 2024
2024, 3 (2): 100076
Original Article | Open Access
Analysis of efficacy and safety for the combination of regorafenib and PD-1 inhibitor in advanced hepatocellular carcinoma: A real-world clinical study
Published: 27 March 2024
2024, 3 (2): 100092
Original Article | Open Access
Clinical outcomes of cessation of nucleoside/nucleotide analogues in Chinese patients with HBeAg-negative chronic hepatitis B
Published: 27 March 2024
2024, 3 (2): 100093
Original Article | Open Access
Metabolic syndrome is associated with significant hepatic fibrosis and steatosis in patients with nonalcoholic steatohepatitis
Published: 24 April 2024
2024, 3 (2): 100094
Original Article | Open Access
Risk factors related to significant hepatic inflammation in patients with acute drug-induced liver injury
Published: 06 May 2024
2024, 3 (2): 100095
Original Article | Open Access
CCL16 inhibits tumor proliferation and metastasis in HCC by impacting CK19 phenotype
Published: 20 May 2024
2024, 3 (2): 100096